Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23–01): a phase 3 randomised controlled trial

The Lancet Oncology - Tập 14 Số 4 - Trang 297-305 - 2013
Viviana Galimberti1, Bernard F. Cole2,3, Stefano Zurrida4, Giuseppe Viale5,6, Alberto Luini7, Paolo Veronesi8,6, Paola Baratella7, Camelia Chifu7, Manuela Sargenti7, Mattia Intra7, Oreste ­Gentilini7, Mauro G. Mastropasqua5, Giovanni Mazzarol5, Samuele Massarut9, J-R Garbay10, Janez Žgajnar11, H Galatius12, A Recalcati13, David Littlejohn14, Monika Bamert15, Marco Colleoni16, Karen N. Price17,3, Meredith M. Regan18,3, Aron Goldhirsch19, Alan S. Coates20, Richard D. Gelber17,18,21,3, Umberto Veronesi22
1Molecular Senology Unit, Senology Division, European Institute of Oncology, Milan, Italy
2Department of Mathematics and Statistics, College of Engineering and Mathematical Sciences, University of Vermont, Burlington, VT, USA
3IBCSG Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA
4Breast Diagnosis and Surgery Unit, Senology Division, European Institute of Oncology, Milan, Italy
5IBCSG Central Pathology Office, Division of Pathology and Laboratory Medicine, European Institute of Oncology, Milan, Italy
6University of Milan, Milan, Italy
7Senology Division, European Institute of Oncology, Milan, Italy
8Integrated Breast Surgery Unit, Senology Division, European Institute of Oncology, Milan, Italy
9Breast Surgery Division, Centro di Riferimento Oncologico, Aviano, Italy
10Department of Surgery, Institut Gustave Roussy, Villejuif, France
11Department of Surgical Oncology, Institute of Oncology, Ljubljana, Slovenia
12Department of Breastsurgery, Herlev Hospital, Herlev, Denmark
13Department of Surgery, Ospedale Alessandro Manzoni, Lecco, Italy
14Riverina Cancer Care Centre, Wagga Wagga, NSW, Australia
15Breast Center, Kantonsspital, Switzerland
16Research Unit in Medical Senology, Department of Medicine, European Institute of Oncology, Milan, Italy
17Frontier Science and Technology Research Foundation, Boston, MA, USA
18Harvard Medical School, Boston, MA, USA
19Department of Medicine, European Institute of Oncology, Milan, Italy
20International Breast Cancer Study Group and University of Sydney, Centennial Park, NSW, Australia
21Harvard School of Public Health, Boston, MA, USA
22European Institute of Oncology, Milan, Italy

Tóm tắt

Từ khóa


Tài liệu tham khảo

Veronesi, 2003, A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer, N Engl J Med, 349, 546, 10.1056/NEJMoa012782

Krag, 1998, The sentinel node in breast cancer—a multicenter validation study, N Engl J Med, 339, 941, 10.1056/NEJM199810013391401

Straver, 2010, Sentinel node identification rate and nodal involvement in the EORTC 10981-22023 AMAROS trial, Ann Surg Oncol, 17, 1854, 10.1245/s10434-010-0945-z

Veronesi, 2010, Sentinel lymph node biopsy in breast cancer: ten-year results of a randomized controlled study, Ann Surg, 251, 595, 10.1097/SLA.0b013e3181c0e92a

Lyman, 2005, American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer, J Clin Oncol, 23, 7703, 10.1200/JCO.2005.08.001

Giuliano, 2011, Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial, JAMA, 305, 569, 10.1001/jama.2011.90

Veronesi, 2009, Axillary metastases in breast cancer patients with negative sentinel nodes: a follow-up of 3548 cases, Eur J Cancer, 45, 1381, 10.1016/j.ejca.2008.11.041

Naik, 2004, The risk of axillary relapse after sentinel lymph node biopsy for breast cancer is comparable with that of axillary lymph node dissection: a follow-up study of 4008 procedures, Ann Surg, 240, 462, 10.1097/01.sla.0000137130.23530.19

Smidt, 2005, Axillary recurrence after a negative sentinel node biopsy for breast cancer: incidence and clinical significance, Ann Surg Oncol, 12, 29, 10.1007/s10434-004-1166-0

Siponen, 2012, Axillary and supraclavicular recurrences are rare after axillary lymph node dissection in breast cancer, World J Surg, 36, 295, 10.1007/s00268-011-1399-6

Van Zee, 2003, A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy, Ann Surg Oncol, 10, 1140, 10.1245/ASO.2003.03.015

Mansel, 2004, European studies on breast lymphatic mapping, Semin Oncol, 31, 304, 10.1053/j.seminoncol.2004.03.003

Olson, 2008, Impact of immediate versus delayed axillary node dissection on surgical outcomes in breast cancer patients with positive sentinel nodes: results from American College of Surgeons Oncology Group Trials Z0010 and Z0011, J Clin Oncol, 26, 3530, 10.1200/JCO.2007.15.5630

Lucci, 2007, Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011, J Clin Oncol, 25, 3657, 10.1200/JCO.2006.07.4062

Viale, 2001, Histologic detection and clinical implications of micrometastases in axillary sentinel lymph nodes for patients with breast carcinoma, Cancer, 92, 1378, 10.1002/1097-0142(20010915)92:6<1378::AID-CNCR1460>3.0.CO;2-Y

2002, 157

2010, 143

1988, Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. An overview of 61 randomized trials among 28,896 women. Early Breast Cancer Trialists' Collaborative Group, N Engl J Med, 319, 1681, 10.1056/NEJM198812293192601

Gray, 1988, A class of K-sample tests for comparing the cumulative incidence of a competing risk, Ann Stat, 16, 1141, 10.1214/aos/1176350951

Veronesi, 2005, Full-dose intraoperative radiotherapy with electrons during breast-conserving surgery: experience with 590 cases, Ann Surg, 242, 101, 10.1097/01.sla.0000167927.82353.bc

Giuliano, 2010, Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial, Ann Surg, 252, 426, 10.1097/SLA.0b013e3181f08f32

Wasif, 2010, Underuse of axillary dissection for the management of sentinel node micrometastases in breast cancer, Arch Surg, 145, 161, 10.1001/archsurg.2009.269

Straver, 2010, Role of axillary clearance after a tumor-positive sentinel node in the administration of adjuvant therapy in early breast cancer, J Clin Oncol, 28, 731, 10.1200/JCO.2008.21.7554

The EORTC. 10981-22023 AMAROS trial website: http://research.nki.nl/amaros/.

Colleoni, 2005, Size of breast cancer metastases in axillary lymph nodes: clinical relevance of minimal lymph node involvement, J Clin Oncol, 23, 1379, 10.1200/JCO.2005.07.094

Goldhirsch, 1998, Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer, J Natl Cancer Inst, 90, 1601, 10.1093/jnci/90.21.1601

Goldhirsch, 2009, Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009, Ann Oncol, 20, 1319, 10.1093/annonc/mdp322

Goldhirsch, 2003, Meeting highlights: updated international expert consensus on the primary therapy of early breast cancer, J Clin Oncol, 21, 3357, 10.1200/JCO.2003.04.576

Goldhirsch, 2011, Panel members. Strategies for subtypes-dealing with the diversity of breast cancer: highlights of the St. Gallen International expert consensus on the primary therapy of early breast cancer 2011, Ann Oncol, 22, 1736, 10.1093/annonc/mdr304